Introduction. The SARS-CoV-2 pandemic has profoundly affected health systems by relocating resources, enforcing restrictive measures and burdening health care workers. The study aims to assess the changes in the treatment and the evolution of cancer patients in a county in Romania, with a population of over a half million inhabitants. Patients and method. Patients with breast, gastric, colorectal, and lung cancer were studied over a two-year period: 14 months before the onset of the pandemic and 10 months after its beginning. The number of new cases of cancer, the number of chemotherapy and radiotherapy sessions, the number of surgeries and deaths from these four types of cancer were recorded. Results. During the pandemic, fewer chemotherapy sessions were administered for all cancers (p<0.0001). The number of radiotherapy sessions for breast (p<0.007) and colorectal cancer (p<0.002) increased by banning patients from going to university hospitals and decreased for lung cancer (p<0.03) which has symptoms similar to those of the SARS-CoV-2 virus. Conclusions. Cancer patients had limited access to chemotherapy. Their diagnosis and treatment were included in the same category as non-life-threatening diseases. Testing, quarantine and travel limitation were not accompanied by additional safe medical services for the oncological patients. The death rate is inconclusive because the time since the onset of the pandemic is shorter than the natural evolution of the types of cancers studied.
| Published in | European Journal of Preventive Medicine (Volume 9, Issue 2) |
| DOI | 10.11648/j.ejpm.20210902.15 |
| Page(s) | 58-62 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Cancer, Pandemic, COVID-19, Chemotherapy, Radiotherapy, Surgery, Mortality, Discrimination, Lockdown, Triage, Policy
| [1] | Cristian Gherasim, (2020). Euronews. Retrived 2 March 2020, from https://www.euronews.com/2020/10/30/colectiv-fire-romania-s-deadly-nightclub-blaze-is-still-an-open-wound-five-years-on. |
| [2] | Nick Thorpe, (2010). BBC News. Retrived 2 March 2020, from https://www.bbc.com/news/world-europe-10996632. |
| [3] | Craig Turp-Balazs, (2021). Emerging Europe. Retrived 2 March 2020, from https://emerging-europe.com/from-the-editor/romania-is-burning/. |
| [4] | Yu J, Ouyang W, Chua MLK et al, SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China, JAMA Oncol. 2020; 6: 1108-1110. |
| [5] | Elkrief A, Desilets A, Papneja N, Cvetkovic L, Groleau C, Lakehal YA, Shbat L, Richard C, Malo J, Belkaid W, Cook E, Doucet S, Tran TH, Jao K, Daaboul N, Bhang E, Loree JM, Miller WH Jr, Vinh DC, Bouganim N, Batist G, Letendre C, Routy B, High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study, Eur J Cancer. 2020 Nov; 139: 181-187. doi: 10.1016/j.ejca.2020.08.017. Epub 2020 Sep 3. |
| [6] | Curigliano G, Banerjee S, Cervantes A, Garassino M, Garrido P, Girard N, Haanen J, Jordan K, Lordick F, Machiels JP, Michielin O, Peters S, Tabernero J, Douillard JY, Pentheroudakis G, Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus, Ann Oncol 2020 Oct; 31 (10): 1320-1335. doi: 10.1016/j.annonc.2020.07.010. Epub 2020 Jul 31. |
| [7] | Rolston KV. Infections in Cancer Patients with Solid Tumors: A Review. Infect Dis Ther. 2017; 6: 69–83. |
| [8] | Marano L, Marrelli D, Roviello F, Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology. Eur J Surg Oncol. 2020; 46: 1184–1185. |
| [9] | Pinheiro RN, Coimbra FJF, Costa-Jr WLD, Ribeiro HSC, Ribeiro R, Wainstein AJA, Laporte GA, Coelho-Jr MJP, Fernandes PHS, Cordeiro EZ, Sarmento BJQ, Guimaraes-Filho MAC, Anghinoni M, Baiocchi G, Oliveira AF, Surgical cancer care in the COVID-19 era: front line views and consensus, Rev Col Bras Cir. 2020; 47: e20202601. doi: 10.1590/0100-6991e-20202601. Epub 2020 Jul 3. PMID: 32638914. |
| [10] | NICE, (2021), NICE guidance, Retrived 3 March 2020, https://www.nice.org.uk/guidance/ng162. |
| [11] | Tey J, Soon Y. Y, Koh W. Y, Leong C. N, Choo B. A, Ho F et al, Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis, Oncotarget. 2017; 8: 25797-25805https://doi.org/10.18632/oncotarget.15554. |
| [12] | Calabrò L, Peters S, Soria JC, et al, Challenges in lung cancer therapy during the COVID-19 pandemic, Lancet Respir Med. 2020; 8: 542–544. doi: 10.1016/S2213-2600(20)30170-3. |
| [13] | Catania C, Stati V, Spitaleri G, Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer, Tumori. 2020 Aug 26: 300891620951863. doi: 10.1177/0300891620951863. Online ahead of print, PMID: 32842909. |
| [14] | Marques NP, Silveira DMM, Marques NCT, Martelli DRB, Oliveira EA, Martelli-Júnior H, Cancer diagnosis in Brazil in the COVID-19 era, Semin Oncol. 2021 Jan 7: S0093-7754 (20) 30123-8. doi: 10.1053/j.seminoncol.2020.12.002. |
| [15] | Minucci A, Scambia G, De Bonis M, De Paolis E, Santonocito C, Fagotti A, Capoluongo E, Concolino P, Urbani A, BRCA testing delay during the COVID-19 pandemic: How to act?, Mol Biol Rep. 2021 Jan; 48 (1): 983-987. doi: 10.1007/s11033-020-06060-8. |
| [16] | Al-katib Sayf, Gupta, G, Brudvik A, Ries S., Krauss J, Farah M, A practical guide to managing CT findings in the breast, Clin Imaging. 2020 Apr; 60 (2): 274-282. doi: 10.1016/j.clinimag.2018.07.009. |
| [17] | Kuderer NM., Choueiri T. K., Shah D. P, Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, Lancet. 2020; 395: 1907–1918. doi: 10.1016/S0140-6736(20)31187-9. |
| [18] | Pinato DJ, Zambelli A, Aguilar-Company Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients, Cancer Discov. 2020 doi: 10.1158/2159-8290.CD-20-0773. |
| [19] | Weinkove R, McQuilten ZK, Adler J, Agar MR, Blyth E, Cheng AC, Conyers R, Haeusler GM, Hardie C, Jackson C, Lane SW, Middlemiss T, Mollee P, Mulligan SP, Ritchie D, Ruka M, Solomon B, Szer J, Thursky KA, Wood EM, Worth LJ, Yong MK, Slavin MA, Teh BW, Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance, Med J Aust 2020 Jun; 212 (10): 481-489. doi: 10.5694/mja2.50607. |
| [20] | Wake RM, Morgan M, Choi J, Winn S, Reducing nosocomial transmission of COVID-19: implementation of a COVID-19 triage system, Clin Med (Lond) 2020 Sep; 20 (5): e141-e145. doi: 10.7861/clinmed.2020-0411. |
| [21] | Rosti ME, Olivieri S, Cavaiola M, Seminara A, Mazzino A, Fluid dynamics of COVID-19 airborne infection suggests urgent data for a scientific design of social distancing, Sci Rep. 2020 Dec 30; 10 (1): 22426. doi: 10.1038/s41598-020-80078-7. |
| [22] | Leasa D, Cameron P, Honarmand K, Mele T, Bosma KJ; LHSC Ventilation Strategy for COVID-19 Working Group, Knowledge translation tools to guide care of non-intubated patients with acute respiratory illness during the COVID-19 Pandemic, Crit Care. 2021 Jan 8; 25 (1): 22. doi: 10.1186/s13054-020-03415-2. |
APA Style
Mihaela Leşe, Raul Micu-Chiş, Ioana Leşe. (2021). Management of Cancer Patients During the SARS-CoV-2 Pandemic, in a County in Romania. European Journal of Preventive Medicine, 9(2), 58-62. https://doi.org/10.11648/j.ejpm.20210902.15
ACS Style
Mihaela Leşe; Raul Micu-Chiş; Ioana Leşe. Management of Cancer Patients During the SARS-CoV-2 Pandemic, in a County in Romania. Eur. J. Prev. Med. 2021, 9(2), 58-62. doi: 10.11648/j.ejpm.20210902.15
AMA Style
Mihaela Leşe, Raul Micu-Chiş, Ioana Leşe. Management of Cancer Patients During the SARS-CoV-2 Pandemic, in a County in Romania. Eur J Prev Med. 2021;9(2):58-62. doi: 10.11648/j.ejpm.20210902.15
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ejpm.20210902.15,
author = {Mihaela Leşe and Raul Micu-Chiş and Ioana Leşe},
title = {Management of Cancer Patients During the SARS-CoV-2 Pandemic, in a County in Romania},
journal = {European Journal of Preventive Medicine},
volume = {9},
number = {2},
pages = {58-62},
doi = {10.11648/j.ejpm.20210902.15},
url = {https://doi.org/10.11648/j.ejpm.20210902.15},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejpm.20210902.15},
abstract = {Introduction. The SARS-CoV-2 pandemic has profoundly affected health systems by relocating resources, enforcing restrictive measures and burdening health care workers. The study aims to assess the changes in the treatment and the evolution of cancer patients in a county in Romania, with a population of over a half million inhabitants. Patients and method. Patients with breast, gastric, colorectal, and lung cancer were studied over a two-year period: 14 months before the onset of the pandemic and 10 months after its beginning. The number of new cases of cancer, the number of chemotherapy and radiotherapy sessions, the number of surgeries and deaths from these four types of cancer were recorded. Results. During the pandemic, fewer chemotherapy sessions were administered for all cancers (p<0.0001). The number of radiotherapy sessions for breast (p<0.007) and colorectal cancer (p<0.002) increased by banning patients from going to university hospitals and decreased for lung cancer (p<0.03) which has symptoms similar to those of the SARS-CoV-2 virus. Conclusions. Cancer patients had limited access to chemotherapy. Their diagnosis and treatment were included in the same category as non-life-threatening diseases. Testing, quarantine and travel limitation were not accompanied by additional safe medical services for the oncological patients. The death rate is inconclusive because the time since the onset of the pandemic is shorter than the natural evolution of the types of cancers studied.},
year = {2021}
}
TY - JOUR T1 - Management of Cancer Patients During the SARS-CoV-2 Pandemic, in a County in Romania AU - Mihaela Leşe AU - Raul Micu-Chiş AU - Ioana Leşe Y1 - 2021/04/20 PY - 2021 N1 - https://doi.org/10.11648/j.ejpm.20210902.15 DO - 10.11648/j.ejpm.20210902.15 T2 - European Journal of Preventive Medicine JF - European Journal of Preventive Medicine JO - European Journal of Preventive Medicine SP - 58 EP - 62 PB - Science Publishing Group SN - 2330-8230 UR - https://doi.org/10.11648/j.ejpm.20210902.15 AB - Introduction. The SARS-CoV-2 pandemic has profoundly affected health systems by relocating resources, enforcing restrictive measures and burdening health care workers. The study aims to assess the changes in the treatment and the evolution of cancer patients in a county in Romania, with a population of over a half million inhabitants. Patients and method. Patients with breast, gastric, colorectal, and lung cancer were studied over a two-year period: 14 months before the onset of the pandemic and 10 months after its beginning. The number of new cases of cancer, the number of chemotherapy and radiotherapy sessions, the number of surgeries and deaths from these four types of cancer were recorded. Results. During the pandemic, fewer chemotherapy sessions were administered for all cancers (p<0.0001). The number of radiotherapy sessions for breast (p<0.007) and colorectal cancer (p<0.002) increased by banning patients from going to university hospitals and decreased for lung cancer (p<0.03) which has symptoms similar to those of the SARS-CoV-2 virus. Conclusions. Cancer patients had limited access to chemotherapy. Their diagnosis and treatment were included in the same category as non-life-threatening diseases. Testing, quarantine and travel limitation were not accompanied by additional safe medical services for the oncological patients. The death rate is inconclusive because the time since the onset of the pandemic is shorter than the natural evolution of the types of cancers studied. VL - 9 IS - 2 ER -
Information
Email: